Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride.
about
Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye dropsHybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyesCytoprotective effect of lacritin on human corneal epithelial cells exposed to benzalkonium chloride in vitroEfficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension.Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications.Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride.Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells.Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model.Incidence and pattern of dry eye after cataract surgeryThe Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients.The course of dry eye after phacoemulsification surgery.Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients.Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndromeFixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.New instruments for dry eye diagnosis.Safety and comfort evaluation of a new formulation of Visine(®) lubricant eye drops containing HydroBlend™ and GentlePur™Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma.Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.Overview of the [corrected] travoprost /timolol BAK-free fixed combination.Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.Ocular drug delivery systems: An overview.Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure.N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study.Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK).Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study.Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost.Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension.Changes in corneal parameters at confocal microscopy in treated glaucoma patients.Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma.Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells.Effect of preserved and preservative-free timolol eye drops on tear film stability in healthy AfricansShort-term comparative study of the effects of preserved and unpreserved topical levofloxacin on the human ocular surface.Acute Corneal Toxicity of Combined Antiglaucoma Topical Eyedrops.Acute corneal toxicity of latanoprost with different preservatives.Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations.Tear fluid-eye drops compatibility assessment using surface tension.Corneal Thickness Response after Anesthetic Eye Drops: Our Own Results and Meta-Analysis.
P2860
Q27009083-16163377-A2F1-42E2-B770-9D40E3CCE8F2Q28543935-125E796F-57A8-4765-8D5A-2A4945DC103CQ30389442-3D33EB3D-3516-41E6-9B14-CB538E5EE85BQ30435051-7338709D-20D6-4CE8-AB14-4E27247D0662Q33819802-E54B5E4E-2FEC-415B-BF2A-66FA1BA6292FQ34206447-756809FB-EAE2-4AFF-9A9F-0D5767C0137EQ34245277-8EE049DC-8F82-41A4-AA6F-383189B990CAQ34357225-6A768EB3-2629-4640-AC7E-80B74D6A1CE4Q34708156-627059EA-93A2-4F68-B1E0-F937171E2A16Q35050334-8FD402B3-CDB3-4526-9DDD-59C7BD444782Q35639470-FC9A5166-4593-4739-B577-8E0CEBEE0CBBQ35677672-4795952E-9212-4863-B944-6CBAC43161AEQ35761832-88D499C9-F9CC-4768-8B05-9979A0FB4990Q36048835-9E8A5DF0-C5B8-43FB-AA2F-1670D1D6BB6CQ36158856-71FE0709-E886-46A0-B435-6EFF83B64B35Q36195244-38E1D2F5-842C-4EF7-9255-A61EF3E4F6E5Q36617867-76B92B31-708D-4F3B-9BCE-E6816B5B22B3Q36908446-9BF7DB9F-9FC7-477C-A303-54DEFBD7C79AQ37856242-A8042787-D6B1-41BB-8A16-198609D7E709Q37987586-4D9FA43B-B5F1-4FEA-8FF8-3BC75C0DE7EDQ38133883-F7A7D9F8-BD6E-4059-B77B-36081EBE4AC8Q38318837-CFC23179-5A57-404F-ACE5-E8A5BCA5DF78Q38443489-B0813045-096A-4D74-A1C5-D7EB93B8CA76Q38698730-49B635FC-00C9-42EA-83C9-63A2F82D54EDQ38843414-FDD01B55-8DA2-4BA1-B928-B86475DB1AF2Q41226964-9FA240BB-C88B-4916-A978-47A30BFD595DQ41431150-70C8E663-6104-4E2D-999B-98A0D748EF8DQ41703661-0BD4AD84-213E-4ACC-B8D8-625F71D34FA8Q42043693-62E2D495-0C73-46D5-833F-7CF118AFC6E9Q42075931-12248E02-A6B1-430A-AF20-E4D97019D196Q42181227-A219E2C8-648A-421D-9F73-9C504BF483BBQ42769999-F5CDA30E-5F9F-488D-8033-7969F4462F32Q42777455-816D1236-48EB-46BD-8515-1C8B58C2C5E0Q43021428-8821A1BC-BF83-4282-8848-1A7EAE153455Q46240094-8CA313B1-DAF6-476A-BBB6-9954F7541B77Q46715705-1A599D99-C9AA-4595-BDC9-DB70003B59DEQ47381165-A2DDDE9B-0A39-469C-BA74-90657182C153Q47412971-14094946-FF8C-4C9E-AC30-95A9101D5FC0Q52917868-546C7ECB-18DF-47E5-8AA0-EB230B9C99F3Q55014754-0C7F9E9A-97B4-44F4-87C3-3F08A4378705
P2860
Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Comparison of the short-term e ...... without benzalkonium chloride.
@ast
Comparison of the short-term e ...... without benzalkonium chloride.
@en
type
label
Comparison of the short-term e ...... without benzalkonium chloride.
@ast
Comparison of the short-term e ...... without benzalkonium chloride.
@en
prefLabel
Comparison of the short-term e ...... without benzalkonium chloride.
@ast
Comparison of the short-term e ...... without benzalkonium chloride.
@en
P2093
P1433
P1476
Comparison of the short-term e ...... without benzalkonium chloride.
@en
P2093
Norihiko Yokoi
Shigeru Kinoshita
Takeshi Ishibashi
P304
P356
10.1097/00061198-200312000-00008
P577
2003-12-01T00:00:00Z